Skip to main content

Table 1 Exclusion criteria for participation of hospitals and patients

From: The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trial

Hospitals Patients
- Hospitals considering to abandon the use of EPO or blood salvage on their own initiative
- Hospitals participating in trials that interfere with the use or the discontinuation of EPO or blood salvage
- Hospitals in which orthopedic surgeons or anesthesiologists are employed who are also employed at another participating hospital or hospitals with partnerships with another participating hospital
- Hospitals that perform less than 50 THA or TKA within 5 months
- Bilateral surgery
- Revision surgery
- Patients with a malignancy (except skin cancer or cured cancers)
- A serious disorder of the coronary, peripheral and/or carotid arteries, a recent myocardial infarction or CVA (past 6 months)
- Untreated hypertension (diastolic BP >95 mmHg)
- Patients with a pregnancy
- Patients with a coagulation disorder
- Patients refusing or with a contraindication for allogeneic blood transfusions
- Patients with untreated anemia, Hb <10 g/dl